Please use this identifier to cite or link to this item: https://essuir.sumdu.edu.ua/handle/123456789/87786
Or use following links to share this resource in social networks: Recommend this item
Title Fake COVID-19 vaccinations in Africa
Authors Aborode, A.T.
Awuah, W.A.
Talukder, S.
Oyeyemi, A.A.
Nansubuga, E.P.
Machai, P.
Tillewein, H.
Oko, C.I.
Keywords COVID-19
COVAX programme
Africa
Type Article
Date of Issue 2022
URI https://essuir.sumdu.edu.ua/handle/123456789/87786
Publisher BMJ
License Creative Commons Attribution - NonCommercial 4.0 International
Citation Aborode AT, Awuah WA, Talukder S, et al. Fake COVID-19 vaccinations in Africa. Postgraduate Medical Journal 2022;98:317-318.
Abstract Deliveries of vaccine supplies by the COVAX programme under the WHO commenced in February 2021.1 COVAX has proposed to distribute 520 million doses to Africa by the end of 2021.1 On 28 March 2021, African Union member states endorsed purchasing 220 million doses of the Johnson & Johnson single shot of the COVID-19 vaccine. However, priority was given to the Johnson & Johnson vaccine to the central-most pooled procurement due to being a single-shot vaccine, being cheap and easy to administer, having good storage conditions and production of doses being within Africa, with fill–finish activities taking place in South Africa.
Appears in Collections: Наукові видання (МІ)

Views

Germany Germany
1
Greece Greece
1
Ireland Ireland
1
Ukraine Ukraine
1
United Kingdom United Kingdom
1
United States United States
557
Vietnam Vietnam
183

Downloads

Canada Canada
1
Germany Germany
1
Nigeria Nigeria
1
United Kingdom United Kingdom
1
United States United States
746
Vietnam Vietnam
1

Files

File Size Format Downloads
Aborode_et_al_Covid-19_2022.pdf 177,5 kB Adobe PDF 751

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.